Viewing StudyNCT03066661



Ignite Creation Date: 2024-05-06 @ 9:45 AM
Last Modification Date: 2024-10-26 @ 12:19 PM
Study NCT ID: NCT03066661
Status: NO_LONGER_AVAILABLE
Last Update Posted: 2019-04-26
First Post: 2017-02-23

Brief Title: Expanded Access to Entrectinib for Cancers With NTRK123 ROS1 or ALK Gene Fusions
Sponsor: Hoffmann-La Roche
Organization: Hoffmann-La Roche

Organization Data

Organization: Hoffmann-La Roche
Class: INDUSTRY
Study ID: Entrectinib RXDX-101 - EAP
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Hoffmann-La Roche
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators